Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Medications to treat HIV are effective, but not curative. Now researchers at Johns Hopkins say they’re working on a new treatment – and it’s one already in use for cancer patients. They are very ...

Florida's recent decision to narrow eligibility for the Ryan White AIDS Drug Assistance Program (ADAP) is expected to limit ...

Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...

The US HIV/AIDS Strategy and Ending the HIV Epidemic (EHE) initiatives aim to reduce HIV transmission by 90% by 2030 through targeted care and prevention initiatives such as the Undetectable = ...

Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV, ...

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

Researchers found that lithium can suppress HIV reactivation in lab-grown human cells through an unexpected, ...

Anemia is a common complication of HIV. There are numerous possible causes, including HIV itself, related infections, and some HIV medications. Taking certain medications and adjusting nutrition may ...

Research into this new way of treating HIV is only beginning. When it was first named in 1983, HIV was thought to be a death sentence. The virus replicated rapidly in the people it infected because ...